Psychologists in La Mirada, CA Accepting Medicare

17 Psychologists found. Showing 1 - 17

Dr. James Michael Woody, PSY.D. Psychologist - Clinical Medicare: Not Enrolled in Medicare Practice Location: 12625 La Mirada Blvd, Suite 202, La Mirada, CA 90638 Phone: 562-903-4800

Dr. Melanie A. Taylor, PSY.D. Psychologist - Clinical Medicare: Not Enrolled in Medicare Practice Location: 12625 La Mirada Blvd, Suite 202, La Mirada, CA 90638 Phone: 562-903-4800    Fax: 562-903-4802

Dr. Elisa Shepard, PH.D. Psychologist - Clinical Medicare: Not Enrolled in Medicare Practice Location: 12625 La Mirada Blvd Ste 202, La Mirada, CA 90638 Phone: 562-903-4800

Jacqueline Gattis, PHD Psychologist - Clinical Medicare: Not Enrolled in Medicare Practice Location: 12625 La Mirada Blvd, 202, La Mirada, CA 90638 Phone: 562-903-4800

Dr. Keith John Edwards, PH.D. Psychologist - Clinical Medicare: Not Enrolled in Medicare Practice Location: 12625 La Mirada Blvd, Suite 202, La Mirada, CA 90638 Phone: 562-903-4800    Fax: 562-903-4802

Dr. Laura K Pedigo, PSYD Psychologist Medicare: Not Enrolled in Medicare Practice Location: 12625 La Mirada Blvd, Suite 202, La Mirada, CA 90639 Phone: 562-903-4800    Fax: 562-903-4802

Dr. Miriam Elizabeth Lewis Hall, PH.D. Psychologist - Clinical Medicare: Not Enrolled in Medicare Practice Location: 12625 La Mirada Blvd, Suite 202, La Mirada, CA 90638 Phone: 562-903-4800    Fax: 562-903-4864

Todd W Hall, PHD Psychologist - Clinical Medicare: Not Enrolled in Medicare Practice Location: 12625 La Mirada Blvd, 202, La Mirada, CA 90638 Phone: 562-903-4800

Dr. Nancy Sherman Duvall, PH.D. Psychologist - Clinical Medicare: Not Enrolled in Medicare Practice Location: 12625 La Mirada Blvd, # 202, Biola Counseling Center, La Mirada, CA 90638 Phone: 562-903-4800    Fax: 562-903-4802

Besty A Barber, PSYD Psychologist - Clinical Medicare: Not Enrolled in Medicare Practice Location: 12625 La Mirada Blvd, 202, La Mirada, CA 90638 Phone: 562-903-4800

Dr. David Cimbora, PH.D. Psychologist - Clinical Medicare: Not Enrolled in Medicare Practice Location: 12625 La Mirada Blvd Ste 202, Biola Counseling Center, La Mirada, CA 90638 Phone: 562-903-4800

Crystal Bowlby, PHD Psychologist - Clinical Medicare: Medicare Enrolled Practice Location: 12625 La Mirada Blvd, 202, La Mirada, CA 90638 Phone: 562-903-4800

John Poston, PHD Psychologist Medicare: Not Enrolled in Medicare Practice Location: 12625 La Mirada Blvd, Biola Counseling Center, La Mirada, CA 90638 Phone: 562-903-4800

Dr. Levon Margolin, PH.D. Psychologist Medicare: Accepting Medicare Assignments Practice Location: 16702 Valley View Ave, La Mirada, CA 90638 Phone: 888-795-0555

Dr. Meridith Lynn Phanco, PH.D. Psychologist - Clinical Medicare: Not Enrolled in Medicare Practice Location: 12625 La Mirada Blvd Ste 202, La Mirada, CA 90638 Phone: 562-903-4800    Fax: 562-903-4802

Dr. Tina Rose Houston-armstrong, PH.D. Psychologist Medicare: Not Enrolled in Medicare Practice Location: 14311 Grayville Dr, La Mirada, CA 90638 Phone: 626-260-4199

Nancy Crawford, PSYD Psychologist - Clinical Medicare: Not Enrolled in Medicare Practice Location: 12625 La Mirada Blvd, 202, La Mirada, CA 90638 Phone: 562-903-4800

News Archive

AstraZeneca submits sNDA for SEROQUEL XR for treatment of major depressive disorder

AstraZeneca has announced the submission of a supplemental New Drug Application (sNDA) to the U.S. Food and Drug Administration (FDA) for once- daily SEROQUEL XR (quetiapine fumarate) Extended-Release Tablets to seek approval for the treatment of major depressive disorder (MDD) as monotherapy, adjunct therapy, and maintenance therapy in adult patients.

Oxford Finance leads $30 million credit facility provided to Cadence for launch of OFIRMEV

Oxford Finance Corporation, a subsidiary of Sumitomo Corporation, today announced that it was the lead lender for a $30 million credit facility provided to Cadence Pharmaceuticals. Silicon Valley Bank and GE Financial Services, Inc. also participated in the loan agreement. This infusion of capital will support the company's potential launch of their investigational product candidate, OFIRMEV™, an intravenous formulation of acetaminophen that is currently marketed in Europe for the treatment of acute pain and fever.

Drug shows early promise in treating patients with small-cell lung cancer

An early round of clinical testing shows that users of Opdivo, a drug sanctioned for treatment of small-cell lung cancer, more than tripled their five-year survival rate beyond the statistical average.

Yellow fever outbreak in Brazil necessitates vaccination for travelers

Brazil is in the midst of a yellow fever outbreak, with the mosquito-borne virus reaching popular tourist destinations that do not normally see the disease. Since January 2018, 10 cases of yellow fever have been confirmed in international travelers visiting Brazil, including four deaths.

Read more Medical News

› Verified 1 days ago